Archives

by in
Entry Author Date Location
How Can San Diego Win the Fight Against Diabesity? Xconomy to Dig Deep on Jan. 27 12/27/10 San Diego
Editor’s Picks: Xconomy Boston’s Top 20 Stories of 2010 12/27/10 Boston
Navy’s Goal Could Improve Economics of Biofuel Development, Arena Plans More Studies of Weight-Loss Drug, Lpath Signs Deal With Pfizer for Eye Drug, & More San Diego Life Sciences News 12/23/10 San Diego
Vivus Submits Document to FDA 12/14/10 San Francisco
FDA Panel Recommends Orexigen’s Obesity Drug, Sequenom Raises Capital, CommNexus Reorganizes Its Free Incubator, & More San Diego Life Sciences News 12/09/10 San Diego
Orexigen Beats the Odds, Wins OK from FDA Panel for Obesity Drug 12/07/10 San Diego
San Diego’s Fight Against Diabesity: Can Investors Make Money, and Can Startups Still Thrive? 12/03/10 San Diego
The Fight Against Diabesity: How Will San Diego Adapt in the Era of Tough FDA Scrutiny? 11/22/10 San Diego
Ambit Files for IPO, Arena Pharmaceuticals Says Weight-Loss Drug on Track, ESRI Launches Medical Place History Map App, & More San Diego Life Sciences News 11/12/10 San Diego
Arena Reloads for Round 2 with FDA, With More Data on Weight Loss Drug in Diabetes Patients 11/09/10 San Diego
Hyperion Nails Pivotal Trial, ChemoCentryx Aims High Against Crohn’s, Vivus Shot Down by FDA, & More Bay Area Life Sciences News 11/05/10 San Francisco
Biogen Announces Restructuring, FDA Approves Sunovion Drug, Acceleron Cuts Workforce, & More Boston-Area Life Sciences News 11/05/10 Boston
Ideo Spinoff ShopWell Says Better Health Starts at the Supermarket; Part 3: Food as Data 11/03/10 San Francisco
Energesis Pharmaceuticals, Co-Founded by Sirtris Vet, Seeks to Tap Power of “Good Fat” in Fighting Obesity and Diabetes 11/03/10 Boston
Ideo Spinoff ShopWell Says Better Health Starts at the Supermarket; Part 2: Ingredients of a Startup 11/02/10 San Francisco
ShopWell, Ideo’s First Big Spinoff, Says Better Health Starts at the Supermarket 11/01/10 San Francisco
Vivus Turned Down by FDA 10/29/10 San Francisco
Life Technologies’ CEO Talks Strategy, Phenomix Falls, Arena Pharmaceuticals Grapples With FDA Setback, & More San Diego Life Sciences News 10/28/10 San Diego
Arena Obesity Drug Fails to Win FDA Approval, May Need More Clinical Testing 10/25/10 San Diego
Alkermes Drug Approved for Opioid Addiction, Genzyme Faces Shareholder Lawsuits, NinePoint Gets $33M, & More Boston-Area Life Sciences News 10/15/10 Boston
Gelesis, With Obesity Drug That Swells Up in Stomach, Helps Rats Eat Less 10/11/10 Boston
Vivus Sells Erectile Treatment for $23.5M 10/04/10 San Francisco
FDA Panel Votes Against Arena’s Weight-Loss Drug, ImThera Encouraged by Early Test Results, Novartis Wins FDA Approval for MS Pill, & More San Diego Life Sciences News 09/23/10 San Diego
Arena Pharmaceuticals Obesity Drug Shot Down by FDA Panel 09/16/10 San Diego
Arena Obesity Drug Was Effective by ‘Slim Margin,’ FDA Staff Raises Rat Cancer Concern; Shares Tumble 09/14/10 San Diego
Zogenix Files for IPO, Orexigen Licenses Obesity Drug to Takeda, ImThera Raises Capital For Sleep Apnea, & More San Diego Life Science News 09/09/10 San Diego
Rhythm Boosts Series A Round to $40M, Adds Third Rock Ventures to List of Backers 09/08/10 Boston
Orexigen Nabs $1B Deal With Takeda to Market Obesity Drug, Shares Climb 09/02/10 San Diego
Taris Hires New CEO, Stromedix Hopes Clinical Trial Will Advance, Euthymics Hits the Ground With Series A, & More Boston-Area Life Sciences News 07/23/10 Boston
Tethys Snags $33M in Equity, Debt for Predictive Diabetes Test 07/21/10 San Francisco
Page 3 of 6 « previous page · next page »